CHISA MATSUMOTO

Dr. CHISA MATSUMOTO

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 September 2018 in Hypertension
Verified
Journal Article
Closed access
PDF file
HTHirofumi Tomiyama
Hirofumi Tomiyama
KSKazuki Shiina
Kazuki Shiina
CVCharalambos Vlachopoulos
Charalambos Vlachopoulos
YIYoichi Iwasaki
Yoichi Iwasaki
CMCHISA MATSUMOTO
CHISA MATSUMOTO
AYAkira Yamashina
Akira Yamashina
This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P =0.04), decrease of the estimated glomerular filtration rate (estimate=−2.02, P <0.01), and elevation of the CRP (estimate=0.08×10 −1 , P =0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10 −2 , P <0.01) and CRP (estimate=1.91, P =0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia.

27 December 2022 in Hypertension Research
Verified
Journal Article
Open access
PDF file
CMCHISA MATSUMOTO
CHISA MATSUMOTO
SSShigeru Shibata
Shigeru Shibata
TKTakuya Kishi
Takuya Kishi
SMSatoshi Morimoto
Satoshi Morimoto
MMMasaki Mogi
Masaki Mogi
HRHiromi Rakugi
Hiromi Rakugi
The coronavirus disease 2019 (COVID-19) affects infected patients even after the acute phase and impairs their health and quality of life by causing a wide variety of symptoms, referred to as long COVID. Although the evidence is still insufficient, hypertension is suspected to be a potential risk factor for long COVID, and the occurrence of cardiovascular diseases seems to be a key facet of multiple conditions observed in long COVID. Nonetheless, there are few reports that comprehensively review the impacts of long COVID on hypertension and related disorders. As a sequel to our previous report in 2020 which reviewed the association of COVID-19 and hypertension, we summarize the possible influences of long COVID on hypertension-related organs, including the cardiovascular system, kidney, and endocrine system, as well as the pathophysiological mechanisms associated with the disorders in this review. Given that the clinical course of COVID-19 is highly affected by age and sex, we also review the impacts of these factors on long COVID. Lastly, we discuss areas of uncertainty and future directions, which may lead to better understanding and improved prognosis of clinical problems associated with COVID-19.

12 May 2025 in JMIR Cardio
Verified
Journal Article
Open access
TVThien Vu
Thien Vu
YKYoshihiro Kokubo
Yoshihiro Kokubo
MIMai Inoue
Mai Inoue
MYMasaki Yamamoto
Masaki Yamamoto
Attayeb MohsenAttayeb Mohsen
Attayeb Mohsen
MAMichihiro Araki
Michihiro Araki
Background: Coronary heart disease (CHD) is a major cause of morbidity and mortality worldwide. Identifying key risk factors is essential for effective risk assessment and prevention. A data-driven approach using machine learning (ML) offers advanced techniques to analyze complex, nonlinear, and high-dimensional datasets, uncovering novel predictors of CHD that go beyond the limitations of traditional models, which rely on predefined variables. Objective: This study aims to evaluate the contribution of various risk factors to CHD, focusing on both established and novel markers using ML techniques. Methods: The study recruited 7672 participants aged 30-84 years from Suita City, Japan, between 1989 and 1999. Over an average of 15 years, participants were monitored for cardiovascular events. A total of 7260 participants and 28 variables were included in the analysis after excluding individuals with missing outcome data and eliminating unnecessary variables. Five ML models—logistic regression, random forest (RF), support vector machine, Extreme Gradient Boosting, and Light Gradient-Boosting Machine—were applied for predicting CHD incidence. Model performance was evaluated using accuracy, sensitivity, specificity, precision, area under the curve, F1-score, calibration curves, observed-to-expected ratios, and decision curve analysis. Additionally, Shapley Additive Explanations (SHAPs) were used to interpret the prediction models and understand the contribution of various risk factors to CHD. Results: Among 7260 participants, 305 (4.2%) were diagnosed with CHD. The RF model demonstrated the highest performance, with an accuracy of 0.73 (95% CI 0.64‐0.80), sensitivity of 0.74 (95% CI 0.62‐0.84), specificity of 0.72 (95% CI 0.61‐0.83), and an area under the curve of 0.73 (95% CI 0.65‐0.80). RF also showed excellent calibration, with predicted probabilities closely aligning with observed outcomes, and provided substantial net benefit across a range of risk thresholds, as demonstrated by decision curve analysis. SHAP analysis elucidated key predictors of CHD, including the intima-media thickness (IMT_cMax) of the common carotid artery, blood pressure, lipid profiles (non–high-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), and estimated glomerular filtration rate. Novel risk factors identified as significant contributors to CHD risk included lower calcium levels, elevated white blood cell counts, and body fat percentage. Furthermore, a protective effect was observed in women, suggesting the potential necessity for gender-specific risk assessment strategies in future cardiovascular health evaluations. Conclusions: We developed a model to predict CHD using ML and applied SHAP methods for interpretation. This approach highlights the multifactor nature of CHD risk evaluation, aiming to support health care professionals in identifying risk factors and formulating effective prevention strategies.

1 June 2009 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
HTHirofumi Tomiyama
Hirofumi Tomiyama
CMCHISA MATSUMOTO
CHISA MATSUMOTO
JYJiko Yamada
Jiko Yamada
MYMasanobu Yoshida
Masanobu Yoshida
MOMari Odaira
Mari Odaira
AYAkira Yamashina
Akira Yamashina
Background. This 3-year prospective study in middle-aged Japanese men with prehypertension examined the usefulness of the plasma levels of C-reactive p

29 June 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
HNHiroki Nakano
Hiroki Nakano
KSKazuki Shiina
Kazuki Shiina
TTTakamichi Takahashi
Takamichi Takahashi
MFMasatsune Fujii
Masatsune Fujii
YIYoichi Iwasaki
Yoichi Iwasaki
HTHirofumi Tomiyama
Hirofumi Tomiyama
Background: Hypertension and diabetes frequently coexist; however, it has not yet been clarified if the bidirectional longitudinal relationships between arterial stiffness and hypertension are independent of those between arterial stiffness and diabetes. Methods and Results: In this 16‐year prospective observational study, 3960 middle‐aged employees of a Japanese company without hypertension/diabetes at the study baseline underwent annual repeated measurements of blood pressure, serum glycosylated hemoglobin A 1c levels, and brachial‐ankle pulse wave velocity. By the end of the study period, 664, 779, 154, and 406 subjects developed hypertension, prehypertension, diabetes, and prediabetes, respectively. Increased brachial‐ankle pulse wave velocity at the baseline was associated with a significant odds ratio (per 1 SD increase) for new onset of prehypertension/hypertension with (2.45/3.28; P <0.001) or without (2.49/2.76; P <0.001) coexisting prediabetes/diabetes, but not for new onset of prediabetes/diabetes without coexisting hypertension. Analyses using the latent growth curve model confirmed the bidirectional relationships between brachial‐ankle pulse wave velocity and hypertension, but no such relationship was observed between brachial‐ankle pulse wave velocity and abnormal glucose metabolism. Conclusions: In middle‐aged employees of a Japanese company, while bidirectional relationships were found to exist between increased arterial stiffness and hypertension, such a relationship was not found between increased arterial stiffness and diabetes. Therefore, it appears that increased arterial stiffness may be associated with the development of hypertension but not with that of diabetes.